VALENTINI, GABRIELE
 Distribuzione geografica
Continente #
NA - Nord America 1.226
EU - Europa 553
AS - Asia 134
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 1.916
Nazione #
US - Stati Uniti d'America 1.222
RU - Federazione Russa 265
IE - Irlanda 94
SE - Svezia 88
SG - Singapore 44
CN - Cina 34
IT - Italia 32
PL - Polonia 32
HK - Hong Kong 19
FI - Finlandia 17
IN - India 17
TR - Turchia 15
DE - Germania 9
GB - Regno Unito 6
CA - Canada 4
AT - Austria 2
CH - Svizzera 2
EU - Europa 2
JO - Giordania 2
NL - Olanda 2
VN - Vietnam 2
BY - Bielorussia 1
CZ - Repubblica Ceca 1
FR - Francia 1
KR - Corea 1
NZ - Nuova Zelanda 1
UA - Ucraina 1
Totale 1.916
Città #
Santa Clara 304
Fairfield 155
Dublin 94
Chandler 77
Cambridge 70
Seattle 67
Ashburn 66
Houston 63
Woodbridge 62
Wilmington 59
Singapore 34
Warsaw 32
Lawrence 21
Shanghai 21
Altamura 20
Buffalo 20
Princeton 20
Ann Arbor 15
Izmir 15
Mumbai 15
Boardman 14
Medford 14
Jacksonville 13
Beijing 8
Boston 7
Florence 7
San Diego 5
Moscow 4
Norwalk 4
Toronto 4
Andover 2
Hamburg 2
Helsinki 2
Hong Kong 2
Morgan Hill 2
New York 2
Vienna 2
West Jordan 2
Yubileyny 2
Ahmedabad 1
Antrim 1
Brno 1
Falls Church 1
Groningen 1
Hillsboro 1
Laurel 1
Livorno 1
Minsk 1
Naaldwijk 1
Newcastle upon Tyne 1
North Bergen 1
Nuremberg 1
Old Bridge 1
Redmond 1
Redwood City 1
Rome 1
Seoul 1
Shaoxing 1
Washington 1
Whangarei 1
Yuma 1
Zhengzhou 1
Totale 1.351
Nome #
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis 139
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study 119
Functional disability and its predictors in systemic sclerosis: A study from the DeSScipher project within the EUSTAR group 113
Anti-inflammatory: new trends in the treatment of the patient with systemic sclerosis. 109
Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise. 107
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). 102
The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy. 100
European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research. 100
Prevalence of anti-toxoplasma antibodies in patients with autoimmune diseases. 96
Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosis 96
Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects. 95
European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. 91
Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis. 90
Rheumatology and dermatology: sister specialities in Italy and Malta. 89
Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis. 87
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study 79
[Copernican revolution in the therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs]. 70
Disease-specific quality indicators, guidelines and outcome measures in scleroderma. 68
Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: a pilot study. 61
Colchicine treatment of Behçet's disease in children. 59
Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research 52
Totale 1.922
Categoria #
all - tutte 5.680
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.680


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020239 0 0 0 0 25 40 39 41 47 14 28 5
2020/2021160 28 11 14 8 3 14 2 19 11 31 14 5
2021/2022137 4 12 14 1 7 4 3 7 14 3 26 42
2022/2023357 35 58 34 23 24 66 51 10 35 2 16 3
2023/2024120 7 15 21 7 9 29 4 9 2 5 1 11
2024/2025688 30 119 59 132 348 0 0 0 0 0 0 0
Totale 1.922